Wolff Wiese Magana’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.6K | Sell |
89
-42
| -32% | -$18.7K | 0.02% | 226 |
|
|
2025
Q1 | $63.5K | Sell |
131
-20
| -13% | -$9.7K | 0.04% | 170 |
|
|
2024
Q4 | $60.8K | Sell |
151
-5
| -3% | -$2.01K | 0.04% | 179 |
|
|
2024
Q3 | $72.6K | Buy |
156
+112
| +255% | +$52.1K | 0.05% | 159 |
|
|
2024
Q2 | $20.6K | Sell |
44
-25
| -36% | -$11.7K | 0.02% | 234 |
|
|
2024
Q1 | $28.8K | Sell |
69
-15
| -18% | -$6.27K | 0.02% | 191 |
|
|
2023
Q4 | $34.2K | Sell |
84
-5
| -6% | -$2.03K | 0.03% | 175 |
|
|
2023
Q3 | $30.9K | Sell |
89
-2
| -2% | -$695 | 0.03% | 230 |
|
|
2023
Q2 | $32K | Sell |
91
-17
| -16% | -$5.98K | 0.02% | 234 |
|
|
2023
Q1 | $34K | Sell |
108
-2
| -2% | -$630 | 0.03% | 220 |
|
|
2022
Q4 | $31.8K | Sell |
110
-770
| -88% | -$222K | 0.03% | 223 |
|
|
2022
Q3 | $255K | Buy |
880
+49
| +6% | +$14.2K | 0.2% | 89 |
|
|
2022
Q2 | $234K | Sell |
831
-4,634
| -85% | -$1.3M | 0.17% | 100 |
|
|
2022
Q1 | $1.43M | Sell |
5,465
-143
| -3% | -$37.3K | 0.96% | 31 |
|
|
2021
Q4 | $1.23M | Sell |
5,608
-53
| -0.9% | -$11.6K | 0.79% | 38 |
|
|
2021
Q3 | $1.03M | Sell |
5,661
-3,351
| -37% | -$608K | 0.72% | 42 |
|
|
2021
Q2 | $1.82M | Buy |
9,012
+165
| +2% | +$33.3K | 1.3% | 17 |
|
|
2021
Q1 | $1.9M | Buy |
8,847
+2,396
| +37% | +$515K | 1.49% | 15 |
|
|
2020
Q4 | $1.53M | Buy |
+6,451
| New | +$1.53M | 1.29% | 18 |
|